V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10309942 | 10056090 | 1.73 | 58.5 | null | 2018-03-24 | 2018-07-15 | null | 02 | null | RADIUM 223 | 100068733 |
| 10310557 | 10056094 | 1.82 | 66.6 | null | 2020-12-10 | 2020-12-11 | null | 02 | null | POMALIDOMIDE | 101569667 |
| 10310759 | 10056096 | 1.81 | 90 | Palliative (P) | 2019-05-26 | 2019-06-02 | null | N | N | IMATINIB | 100876879 |
| 10311214 | 10056099 | 1.73 | 61.6 | null | 2017-09-29 | 2020-01-01 | null | N | null | CARBOPLATIN + PEMETREXED | 100183161 |
| 10311223 | 10056100 | 1.66 | null | null | 2016-11-01 | 2016-11-04 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101265307 |
| 10311285 | 10056101 | 1.52 | 72 | null | 2017-07-23 | 2017-07-23 | null | 02 | null | RADIUM 223 | 101599286 |
| 10311978 | 10056106 | 1.68 | 98.4 | Palliative (P) | 2011-03-19 | 2019-05-29 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 100469448 |
| 10311993 | 10056107 | 0 | 0 | null | 2020-01-03 | 2020-01-03 | null | 02 | null | TEMOZOLOMIDE | 100885216 |
| 10311997 | 10056108 | null | null | null | 2021-02-24 | 2022-03-01 | null | null | null | CARBOPLATIN | 101855245 |
| 10312013 | 10056109 | 1.8 | 123 | null | 2018-07-08 | 2018-07-09 | null | 02 | null | RADIUM 223 | 101127575 |
| 10312063 | 10056110 | 1.75 | 70.5 | Curative (C) | null | 2015-11-15 | null | 02 | N | RADIUM 223 | 100383608 |
| 10312651 | 10056115 | 1.61 | 136 | null | 2019-04-28 | 2019-05-06 | null | 02 | null | BORTEZOMIB + DARATUMUMAB | 100691659 |
| 10312818 | 10056117 | 1.81 | 54.6 | Palliative (P) | 2019-01-16 | 2019-01-17 | null | 02 | N | ATEZOLIZUMAB | 100059240 |
| 10312948 | 10056119 | 1.6 | 86.4 | null | 2015-09-16 | 2015-09-23 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 100037406 |
| 10313051 | 10056121 | 1.67 | 73.05 | null | null | 2020-10-07 | null | 02 | Y | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100137289 |
| 10313054 | 10056122 | 1.96 | 61.2 | null | 2018-07-20 | 2018-07-31 | null | 02 | null | RITUXIMAB + VENETOCLAX | 101463948 |
| 10313089 | 10056123 | 1.73 | 68 | null | 2019-05-11 | 2019-05-30 | null | 02 | null | POMALIDOMIDE | 101087261 |
| 10313452 | 10056126 | 1.56 | 60.3 | Palliative (P) | 2018-10-02 | 2019-10-11 | null | 02 | N | POMALIDOMIDE | 101377929 |
| 10313483 | 10056127 | 1.58 | 65.7 | null | 2019-08-01 | 2019-08-08 | null | 02 | N | POMALIDOMIDE | 101398465 |
| 10313570 | 10056128 | 1.55 | 66 | 03 | 2019-02-01 | 2019-04-14 | null | N | N | IMATINIB | 100359168 |
| 10313622 | 10056129 | 1.73 | 93.6 | Palliative (P) | 2019-02-27 | 2019-03-05 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 101528136 |
| 10313990 | 10056132 | 1.59 | 77.2 | null | 2017-07-08 | 2017-08-20 | null | 02 | null | POMALIDOMIDE | 101272565 |
| 10314027 | 10056133 | 1.9 | 79.6 | Curative (C) | null | 2021-12-13 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101036460 |
| 10314034 | 10056134 | 1.77 | 87.4 | 03 | 2016-05-30 | 2016-08-14 | null | 02 | N | CARBOPLATIN | 100080711 |
| 10314040 | 10056135 | null | null | null | 2019-03-08 | 2019-03-14 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101155920 |
| 10314120 | 10056136 | 1.76 | 95.8 | Palliative (P) | 2022-04-02 | 2022-04-06 | null | null | N | CARBOPLATIN + PEMETREXED | 100363131 |
| 10314145 | 10056137 | 1.57 | 60 | Curative (C) | 2020-05-13 | 2020-05-14 | null | 99 | N | IXAZOMIB + LENALIDOMIDE | 100846270 |
| 10314257 | 10056139 | 1.73 | 77 | 03 | 2018-06-18 | 2018-09-24 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 101705102 |
| 10314302 | 10056140 | 1.68 | 87 | null | 2021-01-29 | 2021-01-29 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101500828 |
| 10314342 | 10056141 | 1.8 | 91.1 | null | 2017-09-18 | 2019-08-16 | null | 02 | null | CARBOPLATIN + PEMETREXED | 101083073 |
| 10314422 | 10056142 | 1.74 | 63.6 | null | 2015-01-09 | 2016-08-10 | null | 02 | null | IXAZOMIB + LENALIDOMIDE | 100917660 |
| 10314558 | 10056144 | 1.65 | 99.3 | null | 2019-10-18 | 2019-11-06 | null | 02 | null | CAPECITABINE + IRINOTECAN | 100466669 |
| 10314734 | 10056146 | 1.61 | 96 | Palliative (P) | 2019-03-06 | 2019-03-31 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 100914467 |
| 10314744 | 10056147 | 1.7 | 68.8 | Palliative (P) | 2019-02-05 | 2019-02-08 | CETUXIMAB + IRINOTECAN + FLUOROURACIL | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101623976 |
| 10314776 | 10056148 | 1.55 | 63 | null | 2019-09-08 | 2019-09-08 | Acalabrutinib | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100233325 |
| 10314785 | 10056149 | 1.69 | 91 | null | 2021-02-28 | 2021-04-03 | Carboplatin + Liposomal Doxorubicin | 02 | null | BUSULFAN | 100239859 |
| 10314938 | 10056151 | 1.67 | 58.6 | Palliative (P) | null | 2019-10-26 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 101693462 |
| 10315065 | 10056154 | 1.58 | 75.2 | Palliative (P) | null | 2019-11-13 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100343035 |
| 10315172 | 10056155 | 1.74 | 122.5 | 03 | 2021-01-05 | 2022-04-30 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100768167 |
| 10315209 | 10056156 | 1.7 | 68.8 | null | 2019-12-27 | 2020-01-15 | Cetuximab 14 day | 02 | null | CISPLATIN | 100154729 |
| 10315224 | 10056157 | 1.7 | 66.2 | null | null | 2019-04-19 | CISPLATIN + RT | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101234373 |
| 10315262 | 10056158 | 1.68 | null | Neo-adjuvant (N) | 2022-03-21 | 2022-04-04 | Chlorambucil | 02 | null | CHLORAMBUCIL | 100501485 |
| 10315272 | 10056159 | 1.52 | 60.3 | Disease modification (D) | null | 2018-05-25 | Bortezomib + Panobinostat | 02 | N | BORTEZOMIB + PANOBINOSTAT | 101680651 |
| 10315276 | 10056160 | 1.69 | 90.2 | 03 | 2019-08-25 | 2019-09-01 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101802191 |
| 10315465 | 10056161 | 1.77 | 92 | null | 2019-02-25 | 2019-03-06 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 100888441 |
| 10315485 | 10056162 | 1.88 | 97.8 | Palliative (P) | null | 2019-02-19 | BUSULFAN | 02 | N | DABRAFENIB | 100857408 |
| 10315491 | 10056163 | 1.69 | 64.45 | Palliative (P) | null | 2020-08-21 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101332629 |
| 10315523 | 10056164 | null | null | null | 2018-08-09 | 2018-10-04 | PERTUZUMAB + TRASTUZUMAB | null | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101759330 |
| 10315548 | 10056165 | 1.68 | 81 | null | 2019-09-29 | 2019-11-09 | null | 02 | null | ACALABRUTINIB | 100627000 |
| 10315589 | 10056166 | null | null | Palliative (P) | null | 2019-12-12 | CHLORAMBUCIL + OBINUTUZUMAB | null | N | CHLORAMBUCIL + OBINUTUZUMAB | 100443733 |